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Inflammatory mediators mediate airway smooth muscle contraction through a G protein-coupled receptor-transmembrane protein 16A-voltagedependent Ca 21 Background: Allergic inflammation has long been implicated in asthmatic hyperresponsiveness of airway smooth muscle (ASM), but its underlying mechanism remains incompletely understood. Serving as G protein-coupled receptor agonists, several inflammatory mediators can induce membrane depolarization, contract ASM, and augment cholinergic contractile response. We hypothesized that the signal cascade integrating on membrane depolarization by the mediators might involve asthmatic hyperresponsiveness. Objective: We sought to investigate the signaling transduction of inflammatory mediators in ASM contraction and assess its contribution in the genesis of hyperresponsiveness. Methods: We assessed the capacity of inflammatory mediators to induce depolarization currents by electrophysiological analysis. We analyzed the phenotypes of transmembrane protein 16A (TMEM16A) knockout mice, applied pharmacological reagents, and measured the Ca 21 signal during ASM contraction. To study the role of the depolarization signaling in asthmatic hyperresponsiveness, we measured the synergistic contraction by methacholine and inflammatory mediators both ex vivo and in an ovalbumin-induced mouse model. Results: Inflammatory mediators, such as 5-hydroxytryptamin, histamine, U46619, and leukotriene D 4 , are capable of inducing Ca 21 -activated Cl 2 currents in ASM cells, and these currents are mediated by TMEM16A. A combination of multiple analysis revealed that a G protein-coupled receptor-TMEM16A-voltage-dependent Ca 21 channel signaling axis was required for ASM contraction induced by inflammatory mediators. Block of TMEM16A activity may significantly inhibit the synergistic contraction of acetylcholine and the mediators and hence reduces hypersensitivity. Conclusions: A G protein-coupled receptor-TMEM16A-voltage-dependent Ca 21 channel axis contributes to inflammatory mediator-induced ASM contraction and synergistically activated TMEM16A by allergic inflammatory mediators with cholinergic stimuli. (J Allergy Clin Immunol 2018;141:1259-68.)
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Mammalian airways are innervated by cholinergic nerve fibers, which regulate in vivo airway resistance. 1 In asthmatic airways, the smooth muscle tissue may be infiltrated with inflammatory cells, which produce a large amount of cytokines, chemokines, growth factors, and inflammatory mediators. 2, 3 These inflammatory factors may affect multiple processes in asthmatic pathology. Interestingly, in addition to mediating immunological responses, some mediators, such as histamine, 4 5-hydroxytryptamin (5-HT), 5 prostanoids, 6, 7 and cysteinyl leukotrienes, 8 also directly evoke the contraction of airway smooth muscle cells (ASMCs). 9 Furthermore, the existence of inflammatory mediators also make airway smooth muscle (ASM) more sensitive to other stimuli through a synergistic or augmentation effect, 10, 11 and such a sensitivity is among the essential factors for the formation of asthmatic hyperresponsiveness. The mechanisms by which these mediators regulate smooth muscle contraction and sensitize ASM are incompletely clear. Previous reports have shown that these mediators may bind to their corresponding G protein-coupled receptors (GPCRs) 12 and thus activate G q /G i heterotrimeric G proteins, which cause calcium release from the endoplasmic reticulum through phospholipase C (PLC)/inositol 1,4,5-triphosphate (IP 3 ) signaling. 13, 14 In smooth muscle cells (SMCs), the activation of this signaling cascade may lead to calcium release from the sarcoplasmic reticulum (SR), which is required for myosin light chain kinase (MLCK) activation and the initiation of contraction. There are observations implying that, in addition to IP 3 -induced Ca 21 release, other Ca 21 sources may also be involved in the contraction of inflammatory mediators. For example, histamine causes lower phosphoinositide hydrolysis than cholinergic agents do, but it shows a comparable capacity to induce contraction, 15, 16 and SKF96365, a nonselective antagonist of Ca 21 channels, markedly inhibits ASM contraction induced by many different inflammatory mediators. 17, 18 24 and expressed at low levels in the gut.
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TMEM16A activation is sensitive to [Ca 21 ] i , 25 by mediating VOCI, which may serve as a sensitive Ca 21 signal amplifier to participate in contraction in SMCs. In ASM and internal anal sphincter smooth muscle, even the intrinsic calcium spark may activate TMEM16A to a certain extent or even induce contraction. [26] [27] [28] In this report, we demonstrated that some asthmatic inflammatory mediators may efficiently activate TMEM16A and thereby mediate ASM contraction. These contractile properties of ASM may be conferred by the abundant expression of TMEM16A and mediator receptors. Moreover, we suggest that inflammatory mediator-mediated contraction is regulated by a GPCR/IP 3 /Ca 21 /TMEM16A/voltage-dependent Ca 21 channel (VDCC) signaling cascade, and this cascade may serve as a sensitive mechanism by which ASM responds to physiological and pathological stimuli. Our results emphasize the importance of inflammatory mediators in some types of asthmatic hyperresponsiveness.
METHODS Animals
The animal experiments performed in this study were conducted in accordance with the guideline of the Animal Care and Use Committee of the Model Animal Research Center of Nanjing University (Nanjing, China). Establishment of the floxed allele of Tmem16a in mice has been described previously. 27 Hartley guinea pigs were used in some tests, because histamine and leukotriene D 4 (LTD 4 ) are not potent bronchoconstrictors in mice, 4, 29 while guinea pig ASM shows the same response as the case with humans. 30 
Western blot analysis
Muscle strips were homogenized in 100 mL of lysis buffer as described by Davis et al. 31 The primary antibodies used for the Western blots are summarized in Table E1 in this article's Online Repository at www.jacionline.org. Enhanced chemiluminescence (ECL) reagents (SUDGEN Co, Ltd, Nanjing, China) was used to visualize the blots.
Isolation of ASMCs
Smooth muscle strips were prepared from the trachea and extrapulmonary bronchus of the TMEM16A control (CTR) and knockout (KO) mice (8-20 weeks, both sexes) or Hartley guinea pigs (250-300 g, male), and treated with papain and collagenase as previously described. 28 
Patch-clamp recording
All currents were recorded using a MultiClamp 700B amplifier, Digidata 1440A and pClamp 10 (Molecular Devices, Sunnyvale, Calif). The currents were filtered at 2 kHz and sampled at 10 kHz, and the data were analyzed using Clampfit 10. A whole-cell patch clamp was used to record the Cl 2 currents.
A focal pressurized perfusion (ALA Scientific Instruments, Farmingdale, NY) of 3 mmol/L 5-HT, 1 mmol/L U46619, 3 mmol/L histamine, 100 nmol/L LTD 4 , 3 mmol/L methacholine (MCh), and 10 mmol/L caffeine was administered through the application pipette to induce currents.
Isometric contraction measurement
Isometric contraction of mouse left extrapulmonary bronchi were measured by using a wire myograph (610-M; Danish Myo Technology, Aarhus, Denmark) with 378C Krebs solution. Isometric contraction of guinea pig tracheal and human bronchial smooth muscle strips were measured by using a force transducer (MLT0201, AD Instruments, Bella Vista, New South Wales, Australia). Smooth muscle strips of guinea pig were incubated in a 378C organ bath with modified Krebs solution (mKrebs), 32 while human bronchial strips were measured in Krebs. Human bronchial smooth muscle strips were isolated from lung biopsies of pulmonary cancer patients, from the Department of Thoracic and Cardiovascular Surgery of Jiangsu Province Hospital.
Measurement of Ca 21 signals
The Tmem16a SMKO and CTR mice were crossed with Cre-dependent GCaMP3, a genetically encoded calcium indicator, reporter mice (Ai38D). 33 The GCaMP3 fluorescence of left extrapulmonary bronchial smooth muscle was excited using a 488-nm argon laser, and the images were recorded every 2.5 seconds using a confocal microscope (FV-1000, Olympus, Tokyo, Japan). The dynamics of the Ca 21 signals were determined by the percentage of fluorescence ratio (DF/F0).
Measurement of respiratory resistance
We used the flexiVent system (SCIREQ, Montreal, Quebec, Canada) to measure respiratory resistance. The ventilator was set to generate a tidal volume of 10 mL/kg at a frequency of 150 breaths per minute. Resistance of the respiratory system (Rrs) was measured by a perturbation of SnapShot (SCIREQ, Montreal, Quebec, Canada).
Statistical analysis
The data are presented as the means 6 SEMs. Differences among the groups were determined using an unpaired 2-tailed Student t test or a 2-way ANOVA. A paired 2-tailed t test was also used to evaluate differences in some experiments (labeled in the text). The significance levels were set as follows: not significant (NS) P > .05, *P < .05, **P < .01, ***P < .001, ****P < .0001.
For detailed descriptions of materials and methods, please see the Methods section in the Online Repository at www.jacionline.org.
RESULTS

Inflammatory constrictors induce Cl Ca currents through TMEM16A in ASMCs
Many inflammatory mediator receptors belong to the GPCR family, and their activation generates Cl Ca currents to depolarize the membrane in ASMCs. 34, 35 To determine the molecular nature of these currents, we performed whole cell voltage clamp recording (Fig 1, A) in ASMCs from TMEM16A KO mice and their CTRs. Before the tests, we measured the KO efficiency of TMEM16A protein and Cl Ca currents in ASM (see Fig E1 in the Online Repository at www.jacionline.org). In CTR ASMCs, 3 mmol/L 5-HT elicited inward currents in 11 of 26 SMCs (Fig  1, B and Fig E2, A in the Online Repository at www.jacionline. org). Similar currents were also detected when cells were treated with 1 mmol/L U46619, a stable derivative of thromboxane A 2 (T X A 2 ) 36,37 (Fig 1, C and Fig E2, B) . We found that 3 mmol/L MCh also efficiently induced inward currents, with apparent outward currents (Fig 1, D and Fig E2, C) . Strikingly, deletion of TMEM16A essentially eliminated the inward currents induced by all 3 constrictors (Fig 1, B-D and Fig E2, A and C) . This effect was highly unlikely to be secondary to TMEM16A deletion because the expression of the constrictor receptors remained unchanged in the mutant ASM (see Fig E3 in this article's Online Repository at www.jacionline.org). These data indicate that both cholinergic and inflammatory constrictors share a common mechanism by activating TMEM16A to elicit Cl Ca currents.
We wondered whether TMEM16A also underlies Cl Ca currents evoked by other inflammatory mediators. We selected guinea pigs to test the effects of histamine and LTD 4 , because these 2 mediators are not potent in mice, 4, 29 and guinea pig ASM shows the same response as the case with humans. 30 Fig 1, E and F show that histamine and cysteinyl leukotrienes generated inward currents similar to the Cl Ca current induced by 5-HT and U46619 in mice ASMCs, although the amplitudes varied. These Cl Ca currents result from the opening of TMEM16A channels, because 10 mmol/L T16A inh -A01, a specific inhibitor of TMEM16A, 38 essentially blocked these currents (Fig 1, E and F and Fig E2, D and E) . In sum, TMEM16A underlies inflammatory mediator-induced Cl Ca channel activity in ASM cells from different species.
TMEM16A is required for contractile responses to inflammatory constrictors
We sought to determine the role of TMEM16A in constrictor-mediated contraction using TMEM16A KO and T16A inh -A01-treated ASM ex vivo. We first examined the morphology of airways from KO and CTR mice. As shown in Fig 2, A and B, no apparent morphological difference is noticed, and no apparent change in muscle thickness can be detected in KO bronchus (P > .05, vs CTR, unpaired 2-tailed Student t test). We then compared the contractile responses to different stimuli in ASM from the KO (flox/flox; Cre1) and control mice (flox/1; Cre1 or flox/flox; Cre-). On stimulation with 60 mmol/L KCl or 10 mmol/L MCh, the KO ASM developed a force that was comparable to that of the control muscles (Fig 2, C and D and Fig E4, A and B in the Online Repository at www.jacionline. org), suggesting that these muscles had a normal contractile apparatus. Interestingly, when the KO muscle was treated with MCh at a concentration as low as 300 nmol/L, the evoked force was significantly reduced (KO: 2.58 6 0.68 mN vs CTR: 5.66 6 0.95 mN, P < .05, unpaired 2-tailed Student t test) (see Fig E5 in this article's Online Repository at www.jacionline. org). This result indicates that TMEM16A may be necessary for the contractile response to mild cholinergic stimulation. U46619 induced ASM contraction in a dose-dependent manner (Fig 2, E and Fig E4, C) , and the maximal force induced was comparable to that achieved with MCh (;12 mN for MCh, ;10 mN for U46619). After TMEM16A deletion, 34% to 76% of the force was significantly inhibited (P < .0001 by 2-way ANOVA) (Fig 2, E) , and the extent of inhibition varied with the dosage, as TMEM16A contributed more contraction at low U46619 concentration. We found that 5-HT also evoked CTR ASM contraction in a dose-dependent manner, the maximal force developed was ;5 to 6 mN, which was only one-half of the force induced by U46619 or MCh (Fig 2, F) . To our surprise, TMEM16A-deficient ASM displayed an almost abolished contractile response to various doses of 5-HT (P < .0001, 2-way ANOVA) (Fig 2, F and Fig E4, D) , indicating that the force induced by 5-HT was primarily mediated by TMEM16A. This effect could be further confirmed in vivo, as the elevated Rrs of the The bars represent the means 6 SEMs; *P < .05, **P < .01, ***P < .001, ****P < .0001; 2-tailed Student t test; blue ''*'' for outward currents and red ''*'' for inward currents.
mice challenged with 5-HT was significantly inhibited by TMEM16A deletion (P < .001, 2-way ANOVA) (Fig 2, G) .
We also used ASM from guinea pigs to measure the contractile responses to histamine and LTD 4 . Both constrictors generated force in a dose-dependent manner, as previously reported (Fig 3, C and D) . 30 Next, we used the inhibitor, T16A inh -A01, to assess the role of TMEM16A in histamine-and LTD 4 -induced contraction. The specificity of this inhibitor in ASM was first confirmed using Tmem16a SMKO mice (Fig 3, A and B). Preincubating with T16A inh -A01 largely dropped the basal tone of guinea pig ASM and decreased the capacity of histamine and LTD 4 to induce contraction ( As the doses increased, the inhibition due to T16A inh -A01 was rapidly reduced. When the histamine and LTD 4 doses reached 3 mmol/L and 10 nmol/L, respectively, T16A inh -A01 showed no apparent inhibition effect. Inhibition of TMEM16A shifts the half maximal effective concentration for histamine from 0.18 6 0.07 mmol/L to 1.54 6 0.45 mmol/L (P < .05, unpaired 2-tailed Student t test, n 5 5) and for LTD 4 from 69.09 6 18.76 pmol/L to 2.58 6 0.85 nmol/L (P < .05, unpaired 2-tailed Student t test, n 5 5). These results suggest that TMEM16A is required for the sensitized response to weak stimulation with histamine and LTD 4 . We also tested T16A inh -A01 activity on human bronchial smooth muscle. The addition of 10 mmol/L T16A inh -A01 did not alter the basal tone, but it significantly inhibited the force induced by histamine (Fig 3, E) . Taken together, the genetic deletion or pharmacological inhibition of TMEM16A inhibits the force evoked by inflammatory constrictors, suggesting that TMEM16A is required for the contraction. 33 In ASM from Tmem16a SMKO , 60 mmol/L KCl induced a robust calcium elevation similar to the CTR muscle (Fig 4, A and Video E1 in the Online Repository at J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 4 www.jacionline.org). Also, 3 mmol/L MCh induced an increase in calcium, with an average peak DF/F0 value of 39.67 6 3.44%, which did not differ from the CTR (P 5 .167) (Fig 4, I and Video E2 in the Online Repository at www.jacionline.org). These calcium elevation patterns appeared to be consistent with the corresponding contractile responses ( Fig E5) . Because 5-HT is a primary and typical inflammatory constrictor in mice, we measured the substantial calcium-releasing effect of 5-HT. We found that 300 nmol/L 5-HT induced a smaller rise in the DF/F0 peak value in KO ASM compared with the CTR (Tmem16a SMKO : 6.56 6 1.02% vs CTR: 13.20 6 2.15%; P < .05, unpaired 2-tailed Student t test) (Fig 4, C and Video E3 in this article's Online Repository at www.jacionline.org). When the muscle was treated with a relatively high dose of 5-HT (3 mmol/L), the DF/F0 peak value was 23.00 6 3.29%, which was also significantly lower than the CTR (34.35 6 4.31%) (P < .05, unpaired 2-tailed Student t test) (Fig 4, D and Video E4 in the Online Repository at www. jacionline.org). The DF/F0 value in the sustained phase was significantly reduced in 5-HT-treated KO muscle (P < .001, 2-way ANOVA) (Fig 4, C and D) . We also measured the calcium release induced by other constrictors in Tmem16a SMKO smooth muscles and observed similar trends (data not shown). These results showed that TMEM16A was required for the calcium elevation in response to constrictors.
To determine whether this calcium release was mediated by VDCCs, we examined the effect of nifedipine, a specific inhibitor of L-type Ca 21 channels 39 on constrictor-induced rise of contraction. We found that 1 mmol/L nifedipine reduces both contraction induced by MCh and 5-HT, though to a much greater extent in 5-HT. However, in the KO bronchial smooth muscles, 1 mmol/L nifedipine did not alter the dose-response curves of either MCh or 5-HT (Fig 5, A and B) . Although a previous report 40 suggested that TMEM16A may also regulate Ca 21 release from SR, we did not observe a greater inhibition effect in TMEM16A KO ASM compared with nifedipine-treated CTR ASM (Fig 5) . Collectively, the results suggested that both inflammatory constrictors and a low dose of MCh might regulate ASM contraction through the GPCR-TMEM16A-VDCC axis.
Inflammatory constrictors augment the cholinergic response through TMEM16A and are required for asthmatic hypersensitivity
In asthma, the ASM becomes more sensitive to cholinergic stimulation, which reflects airway hyperresponsiveness. We hypothesized that TMEM16A activation by inflammatory constrictors might be involved in this process. Thus, we measured the ability of different inflammatory constrictors to augment MCh-induced responses. We pretreated mouse ASM with low doses of the constrictors (5-HT: 100 nmol/L; U46619: 30 nmol/L), and found no apparent or weak contraction. The ASM was then treated with low doses of MCh (30 nmol/L or 100 nmol/L), which also evoked no apparent or weak contraction (see Fig E7 in this article' s Online Repository at www.jacionline. org). But the combination of inflammatory constrictors and MCh led to a significant increase in the evoked force (Fig 6, A and Fig  E7) . These augmented effects were significantly inhibited by TMEM16A deletion (P < .05, unpaired 2-tailed Student t test) (Fig 4, A) . The percentage of inhibition of 5-HT and U46619 in the KO was 42.17 6 10.51% and 60.34 6 4.56%, respectively. These results show that the inflammatory constrictors potentiate ASM contraction in response to cholinergic stimulation through TMEM16A.
To determine the possible contribution of this augmented effect in asthmatic constriction, we established an acute asthma model induced by chicken ovalbumin (OVA). Both the CTR and KO asthmatic mice displayed similar inflammatory infiltration and epithelial swelling (see Fig E8 in this article' s Online Repository at www.jacionline.org). The CTR asthmatic animals that were challenged with the allergen (5% OVA) showed an elevated Rrs, as expected, whereas the KO asthmatic animals had a significantly lower Rrs (P < .001, 2-way ANOVA) (Fig 6, B) . Moreover, after challenge with various doses of MCh, the KO animals also displayed reduced airway constriction (Fig 6, C) , but the extent of inhibition varied with the MCh dose. When the MCh dose was <30 mg per mouse, the DRrs was inhibited by 40% in the KO mice, but no inhibition was measured when the doses were increased to 100 to 300 mg per mouse (Fig 6, C inset) . Collectively, these results suggest that inflammatory constrictors may increase the cholinergic response through TMEM16A, thereby regulating asthmatic constriction.
DISCUSSION
In asthmatic airways, a large amount of inflammatory mediators are released from infiltrated immune cells and some directly cause smooth muscle spasms. 12 The molecular mechanism of inflammatory mediator-induced airway contraction remains incompletely understood. In this study, we found that inflammatory constrictors such as 5-HT, T X A 2 , LTD 4 , and histamine were capable of inducing Cl Ca currents in ASMCs by activating the TMEM16A Cl 2 channel, the resultant activation of TMEM16A and calcium influx were necessary for their contractile responses. This regulatory mechanism was also predominantly adopted by a weak cholinergic stimulation in terms of contraction. Because of the abundant expression of TMEM16A in ASM, TMEM16A-based signaling may serve as a sensitive mechanism by which ASM responds to physiological and pathologic stimuli. Moreover, we found that TMEM16A was also required by the synergistic effect of inflammatory mediators and MCh both ex vivo and in asthmatic animals. This effect may well explain why the airway becomes more sensitive to neuronal stimuli during allergenic inflammation in asthma. As such a sensitivity is an essential factor for the formation of asthmatic responsiveness, our results suggest that ASM contractility mediated by the activation of TMEM16A may contribute significantly to asthmatic hyperresponsiveness.
The receptors for inflammatory mediators mediate immune responses through multiple signaling cascades. 12 Among these cascades, calcium release from the SR is mediated by the sequential activation of G q , PLC, and IP 3 /IP 3 receptor (IP 3 R). 13 In this study, we show that in ASM cells that express both TMEM16A and constrictor receptors, the activation of G q /PLC/ IP 3 /IP 3 R signaling can also activate TMEM16A. Several lines of evidence from other reports also support such coupled activation of TMEM16A 41, 42 by this signaling pathway. Thus, inflammatory constrictors may induce 1 more signaling pathway to promote calcium elevation in asthmatic airways, IP 3 /TMEM16A-mediated calcium influx (IT-CI). Based on our observation that TMEM16A inhibition did not always completely abolish the force induced by the constrictors, the functional contribution of IT-CI to the contractile responses may vary according to the constrictor, for example, the contribution to the 5-HT response is more profound than that to T X A 2 . Here, we propose a working model for the regulation of ASM contraction by constrictors (Fig 7) . In this model, ASMC expresses abundant TMEM16A clusters, inflammatory constrictor receptors, and muscarinic receptors. Activation of their corresponding receptors produces IP 3 and promotes calcium release from the SR. The elevated [Ca 21 ] i , in turn, causes TMEM16A activation to generate Cl 2 current and VDCC activation, and VOCI, which activates MLCK. This signaling pathway primarily responds to inflammatory constrictors and cholinergic transmitters, particularly at low concentrations. If the signals triggered by these stimuli are strong enough, then the calcium release from SR or through ROCI and SOCI will be sufficient to directly activate MLCK to contract smooth muscle. A unique property of asthma is that the ASM becomes more sensitive to cholinergic and other stimuli, which underlies 1 aspect of hyperresponsiveness. 43 A synergistic effect of allergenic inflammatory mediators and a cholinergic transmitter is believed to be a possible cause of this effect. 10, 11 In this report, we indeed observed an apparent synergistic effect of inflammatory constrictors and MCh. Importantly, we found that this effect could be significantly blocked by TMEM16A deletion. Because the synergistic effect of the inflammatory constrictors and MCh is more profound at low concentrations, 10, 11 we suggest that the GPCR/TMEM16A/ VDCCs cascade used by the constrictors may play an essential role in asthmatic hyperresponsiveness. The genesis of hyperresponsiveness may be due to the synergistic activation of TMEM16A cluster by combined stimulation of nerve transmitter and inflammatory constrictors that are overproduced in asthmatic airway (Fig 7) . Considering that inhibition of TMEM16A activity is capable of not only directly relaxing ASM but also reducing hyperresponsiveness, we speculate that TMEM16A inhibitors might be an ideal strategy for asthma therapy. In addition, compared with antagonists of inflammatory mediators such as leukotriene antagonists, which have been approved and are effective asthma therapies, 44 an important advantage of TMEM16A inhibition is that it may block multiple constrictors simultaneously and provide improved efficacy.
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Key messages
d TMEM16A activation depolarizes the membrane of ASM and causes calcium influx and contraction, which causes the airway to sensitively respond to several inflammatory mediators and cholinergic stimuli. ; SMA-Cre -mice of both sexes were also used as 1 more control group in some isometric tension measurements as indicated in Fig 2. TMEM16A CTR and KO mice were crossed with Ai38D mice, E1 and both sexes were used for the Ca 21 measurements at 8 to 20 weeks. All mice were in a mixed C57BL/6 and Sv/129 background.
Western blot analysis
Muscle strips isolated from the trachea and extrapulmonary bronchus of CTR and KO mice were homogenized in 100 mL of lysis buffer (20 mmol/L TRIS base, 137 mmol/L NaCl, 2 mmol/L EDTA, 1% Nonidet P 40 (NP-40), 10% glycerol, protease inhibitor cocktail (Roche, Mannheim, Germany) (pH 5 8). E2 Next the homogenates were incubated on ice for 15 minutes and centrifuged at 3000g to remove tissue debris. Then 80 mL of each sample was transferred to a new tube. The protein concentrations were measured with a bicinchoninic acid kit (Pierce BCA protein assay kit, Pierce Biotechnology, Rockford, Ill). The proteins were mixed with 53 sample buffer (10% SDS, 20% glycerol, 0.05% bromophenol blue, 10 mmol/L b-mercapto-ethanol, 200 mmol/L TRIS-HCl, 8 mol/L urea) and then denatured at 958C for 5 minutes. After resolution by SDS-PAGE, the proteins were transferred to a polyvinylidene fluoride membrane and blocked with 5% nonfat milk in RISbuffered saline with Tween, followed by sequential incubation with primary and horseradish peroxidase-conjugated secondary antibodies. The primary antibodies used for the Western blots are summarized in Table E1 . ECL (SUDGEN Co, Ltd, Nanjing, China) was used to visualize the blots.
Immunofluorescence
Paraffin slices (10-mm thick) of the left lobe of the mouse lung were used for immunofluorescence staining. Nonspecific binding of the primary antibodies was blocked by incubating the slices with PBS with Tween buffer containing 1% BSA and 5% nonimmune goat serum. A rabbit anti-TMEM16A polyclonal antibody (1:200 dilution, ab53212, Abcam, Cambridge, UK) and mouse anti-a-smooth muscle actin (SMA) monoclonal antibody (1:500 dilution, Clone 1A4, Thermo Fisher Scientific, Waltham, Mass) were used as primary antibodies. An Alexa Fluor 488-conjugated goat antirabbit antibody (Invitrogen, Thermo Fisher Scientific) diluted 1:250 and an Alexa Fluor 555-conjugated goat antimouse antibody (Invitrogen) diluted 1:250 were used as secondary antibodies. The cell nuclei were stained with 49-6-diamidino-2-phenylindole, dihydrochloride. The images were captured using a confocal microscope (FV-1000, Olympus).
Isolation of ASMCs
Smooth muscle strips were prepared from the trachea and extrapulmonary bronchus of the TMEM16A CTR and KO mice (8-20 weeks, both sexes) or Hartley guinea pigs (250-300 g, male). The resulting tissues were dissected in dissociation medium (DM) (136 mmol/L NaCl, 5.36 mmol/L KCl, 0.44 mmol/ L KH 2 PO 4 , 4.16 mmol/L NaHCO 3 , 0.34 mmol/L Na 2 HPO 4 , 20 mmol/L HEPES, 5.56 mmol/L glucose, 4.9 mmol/L MgCl 2 , pH 7.1). The first digestion was performed with MgCl 2 -free DM containing 30 U/mL papain, 0.2 mmol/L dithiothreitol, and 0.02 mmol/L EDTA, and the second digestion was performed with a solution containing 3 U/mL collagenase 1A, 1 mg/mL BSA, and 0.1 mg/ml deoxyribonuclease I in MgCl 2 -free DM. The tubes from the second digestion were shaken vigorously until most of the clumps disappeared (;20 minutes). After centrifugation at 300g for 2 minutes, the collected cells were washed with MgCl 2 -free DM once by centrifugation at 300g for 2 minutes. The isolated cells were resuspended in DM, transferred to dishes, and stored at 48C. DM was replaced with the bath solution for patch-clamp recording prior to use.
Patch-clamp recording
All currents were recorded using a MultiClamp 700B amplifier, Digidata 1440A and pClamp 10 (Molecular Devices). The currents were filtered at 2 kHz and sampled at 10 kHz, and the data were analyzed using Clampfit 10 (Molecular Devices).
To 
Histopathology
The extrapulmonary bronchi and left lobes of the lung were immersed in 4% Paraformaldehyde (PFA) at 48C overnight and dehydrated in a graded series of ethanol solutions. The tissue was embedded in paraffin, and 10-mm sections were prepared for standard hematoxylin and eosin staining. Standard hematoxylin and eosin staining was performed on paraffin slices (10-mm thick) of the extrapulmonary bronchi and left lobes of the lung as previously described. E4 The thickness of the bronchial smooth muscle layer was measured from the innermost edge to the outermost edge using ImageJ software (National Institutes of Health, Bethesda, Md). The thickness of the smooth muscle layer of the extrapulmonary bronchus was assessed at 3 predetermined bronchiole sites (2 sites near each end close to the cartilage and 1 site in the middle of the smooth muscle layer). Three slices per mouse were measured. To measure the contraction of guinea pig trachea, the tracheas of male Hartley guinea pigs (250-300 g) were quickly removed and placed in ice-cold mKrebs solution (118 mmol/L NaCl, 4.6 mmol/L KCl, 0.5 mmol/L MgCl 2 , 1.8 mmol/L CaCl 2 , 1 mmol/L KH 2 PO 4 , 24.9 mmol/L NaHCO 3 , 11.1 mmol/L glucose), E5 and dissected from the surrounding tissues. Rings comprising 2 tracheal cartilages were cut from the tracheas. To obtain strips, the cartilage opposite the muscle layer was cut. One cartilaginous end of the trachea strip was anchored to the bottom of the muscle bath chamber, and the other end was connected to a force transducer (MLT0201, AD Instruments). Isometric tension was measured using a PowerLab recording device. The trachea strips were maintained in mKrebs oxygenated with an O 2 -CO 2 mixture (95% O 2 -5% CO 2 ) at 378C. The resting tension was adjusted to 1g. The strips were stimulated at least twice with 60 mmol/L KCl before subsequent experiments. The samples were preincubated with 10 mmol/L T16A inh -A01 or dimethyl sulfoxide (DMSO) vehicle for 10 minutes before addition of the reagents.
Isometric contraction measurement
To measure human bronchial smooth muscle contraction, surgically resected samples from lung cancer patients were quickly incubated in icecold, oxygen-saturated HEPES-Tyrode buffer (137 mmol/L NaCl, 2.7 mmol/L KCl, 1.8 mmol/L CaCl 2 , 1 mmol/L MgCl 2 , 5.6 mmol/L glucose, 10 mmol/L HEPES, pH 7.4). After transport to the laboratory, the surrounding tissues were cleaned, and the bronchial smooth muscle tissues were cut into 3-mmwide strips. One end of the strip was anchored to the bottom of the muscle bath chamber, which was filled with Krebs solution oxygenated with an O 2 -CO 2 mixture (95% O 2 -5% CO 2 ) at 378C. The other end was connected to a force transducer (MLT0201, AD Instruments). Because the diameter and thickness of the smooth muscle layer were different in different samples, the suitable resting tension was tested following stimulation with 60 mmol/L KCl. The samples were preincubated with 10 mmol/L T16A inh -A01 or DMSO vehicle for 10 minutes before addition of the reagents.
Measurement of Ca 21 signals in Ai38D reporter mice
The Tmem16a SMKO and CTR mice were crossed with -reporter Ai38D mice. The left extrapulmonary bronchi of both the CTR and KO mice were mounted on a confocal wire myograph (120 cw; Danish Myo Technology) in HEPES-Tyrode buffer (137.0 mmol/L NaCl, 2.7 mmol/L KCl, 1.0 mmol/L MgCl 2 , 1.8 mmol/L CaCl 2 , 10 mmol/L HEPES, 5.6 mmol/L glucose, pH 7.4). The agonists were added using a self-made gravity perfusion system with a flow velocity of ;10 mL/min. The GCaMP3 fluorescence was excited using a 488-nm argon laser, and the images were recorded every 2.5 seconds using a confocal microscope (FV-1000, Olympus). The average fluorescence intensity of the region of interest (bronchial smooth muscle range) was calculated with SV10-ASW software (Olympus), the average fluorescence intensity during the 1 to 2 minutes before stimulation was defined as the initial fluorescence (F0), and the dynamics of the Ca 21 signals were determined by % DF/F0.
Sensitization with OVA
Mice of both sexes were used at 8 to 10 weeks of age. On days 0 and 14, the mice were sensitized with 100 mg of OVA (Sigma-Aldrich, St Louis, Mo) dissolved in 4 mg of aluminium hydroxide (Imject Alum, Pierce) by intraperitoneal injection. E4 The mice were then challenged with aerosolized 1% OVA in PBS for 60 minutes on days 24, 25, and 26. The mice that had received the last challenge within 24 hours were used as acute asthma models.
Mice that received 4 mg of aluminium hydroxide diluted in PBS via intraperitoneal injection and were challenged with aerosolized PBS were used as a nonasthmatic control model.
Measurement of respiratory resistance
We used the flexiVent system (SCIREQ) to measure respiratory resistance. The OVA-sensitized mice were anesthetized with 250 to 300 mg/kg avertin 24 hours after receiving the last challenge of OVA or PBS. The anesthetized mice were cannulated with a blunt mouth 18-gauge metal needle, and the other end of the needle was connected to the rodent ventilator of the flexiVent system. The ventilator was set to generate a tidal volume of 10 mL/kg at a frequency of 150 breaths per minute. The Rrs was measured by a perturbation of SnapShot. The Newtonian resistance was measured by a perturbation of Quick prime-3 (SCIREQ, Montreal, Quebec, Canada). To measure the changes in respiratory resistance after induction with 5% OVA, Rrs values were recorded every minute for 45 minutes after the mice inhaled nebulized OVA for 5 minutes. To measure the changes in respiratory resistance in response to 5-HT challenge, sequential doses (37.5 mg, 75 mg, and 150 mg) of 5-HT were nebulized to challenge the airway, and the maximal Rrs was calculated for every dose within 3 minutes after challenge to generate dose-response curves. To measure the changes in respiratory resistance in response to MCh, sequential doses (10 mg, 30 mg, 100 mg, and 300 mg) of MCh were nebulized to challenge the airway, and the maximal Rrs were calculated for every dose within 3 minutes of challenge. 
